Antilipemic combinations comprising hmg-coa reductase...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/405 (2006.01) A61K 31/205 (2006.01) A61K 31/22 (2006.01) A61K 31/24 (2006.01) A61K 31/351 (2006.01) A61K 31/366 (2006.01) A61P 3/06 (2006.01)

Patent

CA 2375378

A pharmaceutical composition is described, comprising a lipid-lowering drug such as lovastatin, simvastatin, pravastatin and fluvastatin and L-carnitine or an alkanoyl L-carnitine, which, while conserving the efficacy of the lipid-lowering drug, is substantially devoid of the toxic or side effects typical of such drugs.

L'invention concerne une composition pharmaceutique. Cette composition comprend un produit abaissant le taux de lipides, comme la lovastatine, la simvastatine, la pravastatine et la fluvastatine et la L-carnitine ou L-carnitine alcanoyle. Cette composition présente l'avantage de conserver l'efficacité d'un produit abaissant le taux de lipides et d'être sensiblement dépourvu d'effets toxiques ou d'effets secondaires propres à ce type de médicaments.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antilipemic combinations comprising hmg-coa reductase... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antilipemic combinations comprising hmg-coa reductase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antilipemic combinations comprising hmg-coa reductase... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1525635

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.